Lantus 100 IU/mL 5 × 3 mL Insulin Pens [Diabetes Control]

Description

LANTUS 100IU/ML 5×3ML INSULIN PENS – LONG-ACTING INSULIN ANALOG RESEARCH COMPOUND

Lantus 100IU/mL (Insulin Glargine) is a Canadian pharmaceutical grade, long-acting insulin analog prefilled pen formulation. It is designed for research into sustained insulin receptor activation, glucose metabolism, and prolonged signaling dynamics within controlled experimental systems.

Researchers utilize Lantus to investigate long-term insulin bioactivity, receptor binding profiles, and comparative metabolic effects alongside short-acting analogs.

Each package contains five sterile 3mL pens containing 100IU/mL of Insulin Glargine. Every batch is verified by third-party testing to confirm concentration, purity, and molecular identity.

Key experimental uses include receptor pathway studies, glucose uptake modeling, and metabolic duration profiling.

For research and educational purposes only. The customer assumes full responsibility for the proper handling and application of this product.